Last $14.56 USD
Change Today -0.36 / -2.41%
Volume 29.7K
VCYT On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul W. Ladenson M.D.

Member of Clinical Advisory Board, Veracyte, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Mr. Paul W. Ladenson, MD serves as the Editor-In-Chief at the Journal of Clinical Endocrinology and Metabolism. Mr. Ladenson serves as Director of the Division of Endocrinology and Metabolism and as Professor of Medicine, Pathology, Oncology, and Radiation at the Johns Hopkins University School of Medicine. He is a Distinguished University Professor at Johns Hopkins. Mr. Ladenson served as President of the American Thyroid Association. Mr. Ladenson served as Member of ...

Read Full Background

Corporate Headquarters*

7000 Shoreline Court
South San Francisco, California 94080

United States

Phone: 650-243-6300
Fax: 650-243-6301

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
Dartmouth College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VCYT:US $14.56 USD -0.36

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Antonius P. Schuh Ph.D.Chief Executive Officer and Director
TrovaGene, Inc.
$533.1K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERACYTE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.